Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | April 01, 2024 | April 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,900 |
Ending reported balance
After 2024-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-01 · Exercise / conversion · Acquired 296 · Balance 10,932 Row 2 · 2024-04-01 · Sale · Disposed 32 · Balance 10,900 F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2028-05-02 | Direct | 0 |
Reported balance
After 2024-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-01 · Exercise / conversion · Disposed 296 · Balance 0 F2: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 296 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · derivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 296 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 32 | $213.99 | $6,847.68 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,900 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 296 | $16.00 | $4,736.00 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $197.81 | $98,905.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,636 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54 | $197.81 | $10,681.74 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,136 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $193.53 | $96,765.00 |
DisclosureSEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,190 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54 | $193.53 | $10,450.62 |
DisclosureSEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,690 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-24-036798 · tm249390-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2024 Filed Mar 14, 2024 01:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 11, 2024 Filed Mar 14, 2024 01:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $198.05 | $99,025.00 |
DisclosureSEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,744 F3 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 11, 2024 Filed Mar 14, 2024 01:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54 | $198.05 | $10,694.70 |
DisclosureSEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,244 F2 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 11, 2024 Filed Mar 14, 2024 01:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-24-034102 · tm248803-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The prior Form 4 for the Reporting Person dated March 5, 2024 contained a contained a computational error in the total number of securities beneficially owned following the reported transactions. The current total reflects the accurate number of shares held by the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $179.44 | $89,720.00 |
DisclosureSEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,298 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54 | $179.44 | $9,689.76 |
DisclosureSEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,798 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-24-031088 · tm248021-2_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 22:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-086471 · tm2322533-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 22:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $290.47 | $145,235.00 |
DisclosureSEC source: 0001104659-23-086471 · tm2322533-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,852 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 22:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $290.47 | $8,423.63 |
DisclosureSEC source: 0001104659-23-086471 · tm2322533-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,352 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 22:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-086471 · tm2322533-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-084301 · tm2322139-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $304.99 | $152,495.00 |
DisclosureSEC source: 0001104659-23-084301 · tm2322139-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,381 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $304.99 | $8,844.71 |
DisclosureSEC source: 0001104659-23-084301 · tm2322139-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,881 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-084301 · tm2322139-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-082377 · tm2321602-5_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $326.84 | $163,420.00 |
DisclosureSEC source: 0001104659-23-082377 · tm2321602-5_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,910 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $326.84 | $9,478.36 |
DisclosureSEC source: 0001104659-23-082377 · tm2321602-5_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,410 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:50 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-082377 · tm2321602-5_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-080420 · tm2321120-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $310.42 | $155,210.00 |
DisclosureSEC source: 0001104659-23-080420 · tm2321120-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,439 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $310.42 | $9,002.18 |
DisclosureSEC source: 0001104659-23-080420 · tm2321120-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,939 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-080420 · tm2321120-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 21:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-078824 · tm2320715-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 21:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $322.09 | $161,045.00 |
DisclosureSEC source: 0001104659-23-078824 · tm2320715-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,968 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 21:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $322.09 | $9,340.61 |
DisclosureSEC source: 0001104659-23-078824 · tm2320715-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,468 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 21:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-078824 · tm2320715-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-075936 · tm2319984-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $315.87 | $157,935.00 |
DisclosureSEC source: 0001104659-23-075936 · tm2319984-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,497 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $315.87 | $9,160.23 |
DisclosureSEC source: 0001104659-23-075936 · tm2319984-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,997 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-075936 · tm2319984-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-073745 · tm2319459-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $307.64 | $153,820.00 |
DisclosureSEC source: 0001104659-23-073745 · tm2319459-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,026 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $307.64 | $8,921.56 |
DisclosureSEC source: 0001104659-23-073745 · tm2319459-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,526 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-23-073745 · tm2319459-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 21:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-23-071297 · tm2318710-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 21:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $309.03 | $154,515.00 |
DisclosureSEC source: 0001104659-23-071297 · tm2318710-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,555 F2 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 21:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29 | $309.03 | $8,961.87 |
DisclosureSEC source: 0001104659-23-071297 · tm2318710-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,055 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.